Publications by authors named "Nele Kindt"

Claim this Profile
P
PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.
Andrea Casazza, Lawrence Van Helleputte, Britt Van Renterghem, Peter Pokreisz, Natalie De Geest, Nele Kindt

Mol Cancer Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma.
Britt Van Renterghem, Agnieszka Wozniak, Ludovica Tarantola, Andrea Casazza, Jasmien Wellens, Nele Kindt

Biomedicines· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Karolien Hollanders, Inge Van Hove, Jurgen Sergeys, Tine Van Bergen, Evy Lefevere, Nele Kindt

Curr Eye Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
Sarah Van de Velde, Tine Van Bergen, Evelien Vandewalle, Nele Kindt, Karolien Castermans

Prog Brain Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma.
Davine Sijnave, Tine Van Bergen, Karolien Castermans, Nele Kindt, Evelien Vandewalle

Cornea· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological characterization of selective LIMK inhibitors.
Sandro Boland, Arnaud Bourin, Jo Alen, Jacques Geraets, Pieter Schroeders, Nele Kindt

Bioorg Med Chem Lett· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors.
Sandro Boland, Arnaud Bourin, Jo Alen, Jacques Geraets, Pieter Schroeders, Nele Kindt

J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of AMA0428, a novel and potent ROCK inhibitor, in a model of neovascular age-related macular degeneration.
Karolien Hollanders, Tine Van Bergen, Nele Kindt, Karolien Castermans, Dirk Leysen

Invest Ophthalmol Vis Sci· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors.
Sandro Boland, Olivier Defert, Jo Alen, Arnaud Bourin, Karolien Castermans, Nele Kindt

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure.
Nele Kindt, Axel Menzebach, Marlies Van de Wouwer, Inge Betz, Astrid De Vriese

FASEB J· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis